Fireside Chat: The Capital Decision — When (and Whether) to Go Public in Today’s Biotech Market

Session details:

• Evaluate whether to pursue an IPO, remain private, or delay based on company maturity, market conditions, and investor expectations  
• Weigh key tradeoffs across financing paths including dilution, control, timing, and long-term value creation  
• Understand how private equity and crossover investors influence decision-making before an IPO is even on the table  
• Define what “IPO readiness” looks like today from a decision-making standpoint, not just execution  
• Identify scenarios where going public may not be the optimal path and what alternative strategies can unlock greater value